Chinese scientists seek patent for possible coronavirus drug
The antiviral drug remdesivir could be used to treat the virus that has paralysed large parts of China
05 February 2020 - 15:34
Beijing — Chinese researchers have applied for a national patent on an experimental Gilead Sciences drug that they believe might fight the novel coronavirus.
The Wuhan Institute of Virology — based in the Chinese city at the centre of the epidemic — has applied for a patent in China for the use of the antiviral drug, known as remdesivir, in treating the ailment. The application was made on January 21 together with a military academy, according to a February 4 statement on the institute’s website...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.